Cellromax Science Co., Ltd. (KOSDAQ:471820)
5,060.00
-70.00 (-1.36%)
At close: Mar 6, 2026
-0.39% (1Y)
| Market Cap | 54.78B |
| Revenue | n/a |
| Net Income | n/a |
| Shares Out | 11.14M |
| EPS | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 185.00 (3.66%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 24,642 |
| Average Volume | 204,436 |
| Open | 5,130.00 |
| Previous Close | 5,130.00 |
| Day's Range | 4,980.00 - 5,210.00 |
| 52-Week Range | 4,355.00 - 7,690.00 |
| Beta | n/a |
| RSI | 39.93 |
| Earnings Date | Nov 27, 2025 |